Intercept Pharmaceuticals, Inc.

BARCLAYS PLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

3/26/2026

Shares

178,438

Value ($000)

3,308

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	3/26/2026	3,308	0.0%	178,438	9/30/2023
2023 Q2	3/30/2026	2,370	0.0%	214,253	6/30/2023
2023 Q1	3/30/2026	1,569	0.0%	116,826	3/31/2023
2022 Q4	3/30/2026	1,979	0.0%	159,968	12/31/2022
2022 Q3	11/3/2022	2,252	0.0%	161,495	9/30/2022
2022 Q2	8/12/2022	494	0.0%	35,743	6/30/2022
2022 Q1	5/16/2022	1,292	0.0%	79,384	3/31/2022
2021 Q4	2/14/2022	686	0.0%	42,079	12/31/2021
2021 Q3	11/9/2021	296	0.0%	19,969	9/30/2021
2021 Q2	8/13/2021	1,435	0.0%	71,874	6/30/2021
2021 Q1	5/13/2021	2,328	0.0%	100,866	3/31/2021
2020 Q4	2/11/2021	2,300	0.0%	93,137	12/31/2020
2020 Q3	11/12/2020	12,382	0.0%	298,613	9/30/2020
2020 Q2	8/12/2020	10,122	0.0%	211,246	6/30/2020
2020 Q1	5/13/2020	15,726	0.0%	249,773	3/31/2020
2019 Q4	2/10/2020	10,186	0.0%	82,199	12/31/2019
2014 Q1	5/15/2014	105	0.0%	320	3/31/2014
2013 Q4	2/13/2014	947	0.0%	13,931	12/31/2013